File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1186/s12985-023-02008-z
- Scopus: eid_2-s2.0-85152269406
- WOS: WOS:000983756900001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: SARS-CoV-2 infection aggravates cigarette smoke-exposed cell damage in primary human airway epithelia
Title | SARS-CoV-2 infection aggravates cigarette smoke-exposed cell damage in primary human airway epithelia |
---|---|
Authors | |
Keywords | Airway epithelial cells Cigarette smoking COVID-19 SARS-CoV-2 |
Issue Date | 11-Apr-2023 |
Publisher | BioMed Central |
Citation | Virology Journal, 2023, v. 20, n. 1 How to Cite? |
Abstract | BackgroundThe coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a worldwide pandemic with over 627 million cases and over 6.5 million deaths. It was reported that smoking-related chronic obstructive pulmonary disease (COPD) might be a crucial risk for COVID-19 patients to develop severe condition. As cigarette smoke (CS) is the major risk factor for COPD, we hypothesize that barrier dysfunction and an altered cytokine response in CS-exposed airway epithelial cells may contribute to increased SARS-CoV-2-induced immune response that may result in increased susceptibility to severe disease. The aim of this study was to evaluate the role of CS on SARS-CoV-2-induced immune and inflammatory responses, and epithelial barrier integrity leading to airway epithelial damage. MethodsPrimary human airway epithelial cells were differentiated under air-liquid interface culture. Cells were then exposed to cigarette smoke medium (CSM) before infection with SARS-CoV-2 isolated from a local patient. The infection susceptibility, morphology, and the expression of genes related to host immune response, airway inflammation and damages were evaluated. ResultsCells pre-treated with CSM significantly caused higher replication of SARS-CoV-2 and more severe SARS-CoV-2-induced cellular morphological alteration. CSM exposure caused significant upregulation of long form angiotensin converting enzyme (ACE)2, a functional receptor for SARS-CoV-2 viral entry, transmembrane serine protease (TMPRSS)2 and TMPRSS4, which cleave the spike protein of SARS-CoV-2 to allow viral entry, leading to an aggravated immune response via inhibition of type I interferon pathway. In addition, CSM worsened SARS-CoV-2-induced airway epithelial cell damage, resulting in severe motile ciliary disorder, junctional disruption and mucus hypersecretion. ConclusionSmoking led to dysregulation of host immune response and cell damage as seen in SARS-CoV-2-infected primary human airway epithelia. These findings may contribute to increased disease susceptibility with severe condition and provide a better understanding of the pathogenesis of SARS-CoV-2 infection in smokers. |
Persistent Identifier | http://hdl.handle.net/10722/338242 |
ISSN | 2023 Impact Factor: 4.0 2023 SCImago Journal Rankings: 1.016 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chen, Rui | - |
dc.contributor.author | Hui, Kenrie Pui-Yan | - |
dc.contributor.author | Liang, Yingmin | - |
dc.contributor.author | Ng, Ka-Chun | - |
dc.contributor.author | Nicholls, John Malcolm | - |
dc.contributor.author | Ip, Mary Sau-Man | - |
dc.contributor.author | Peiris, Malik | - |
dc.contributor.author | Chan, Michael Chi-Wai | - |
dc.contributor.author | Mak, Judith Choi-Wo | - |
dc.date.accessioned | 2024-03-11T10:27:20Z | - |
dc.date.available | 2024-03-11T10:27:20Z | - |
dc.date.issued | 2023-04-11 | - |
dc.identifier.citation | Virology Journal, 2023, v. 20, n. 1 | - |
dc.identifier.issn | 1743-422X | - |
dc.identifier.uri | http://hdl.handle.net/10722/338242 | - |
dc.description.abstract | <h3>Background</h3><p>The coronavirus disease 2019 (COVID-19), which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has become a worldwide pandemic with over 627 million cases and over 6.5 million deaths. It was reported that smoking-related chronic obstructive pulmonary disease (COPD) might be a crucial risk for COVID-19 patients to develop severe condition. As cigarette smoke (CS) is the major risk factor for COPD, we hypothesize that barrier dysfunction and an altered cytokine response in CS-exposed airway epithelial cells may contribute to increased SARS-CoV-2-induced immune response that may result in increased susceptibility to severe disease. The aim of this study was to evaluate the role of CS on SARS-CoV-2-induced immune and inflammatory responses, and epithelial barrier integrity leading to airway epithelial damage.</p><h3>Methods</h3><p>Primary human airway epithelial cells were differentiated under air-liquid interface culture. Cells were then exposed to cigarette smoke medium (CSM) before infection with SARS-CoV-2 isolated from a local patient. The infection susceptibility, morphology, and the expression of genes related to host immune response, airway inflammation and damages were evaluated.</p><h3>Results</h3><p>Cells pre-treated with CSM significantly caused higher replication of SARS-CoV-2 and more severe SARS-CoV-2-induced cellular morphological alteration. CSM exposure caused significant upregulation of long form angiotensin converting enzyme (ACE)2, a functional receptor for SARS-CoV-2 viral entry, transmembrane serine protease (TMPRSS)2 and TMPRSS4, which cleave the spike protein of SARS-CoV-2 to allow viral entry, leading to an aggravated immune response via inhibition of type I interferon pathway. In addition, CSM worsened SARS-CoV-2-induced airway epithelial cell damage, resulting in severe motile ciliary disorder, junctional disruption and mucus hypersecretion.</p><h3>Conclusion</h3><p>Smoking led to dysregulation of host immune response and cell damage as seen in SARS-CoV-2-infected primary human airway epithelia. These findings may contribute to increased disease susceptibility with severe condition and provide a better understanding of the pathogenesis of SARS-CoV-2 infection in smokers.</p> | - |
dc.language | eng | - |
dc.publisher | BioMed Central | - |
dc.relation.ispartof | Virology Journal | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | Airway epithelial cells | - |
dc.subject | Cigarette smoking | - |
dc.subject | COVID-19 | - |
dc.subject | SARS-CoV-2 | - |
dc.title | SARS-CoV-2 infection aggravates cigarette smoke-exposed cell damage in primary human airway epithelia | - |
dc.type | Article | - |
dc.identifier.doi | 10.1186/s12985-023-02008-z | - |
dc.identifier.scopus | eid_2-s2.0-85152269406 | - |
dc.identifier.volume | 20 | - |
dc.identifier.issue | 1 | - |
dc.identifier.eissn | 1743-422X | - |
dc.identifier.isi | WOS:000983756900001 | - |
dc.identifier.issnl | 1743-422X | - |